Nalaganje...
Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy
More than 10 clinical trials of Aβ immunotherapy are currently underway in patients with Alzheimer’s disease (AD). The aim is to identify safe approaches for the efficacious antibody-mediated removal of brain β-amyloid or its neurotoxic oligomeric precursors consisting of aggregated amyloid β-peptid...
Shranjeno v:
| izdano v: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer-Verlag
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084243/ https://ncbi.nlm.nih.gov/pubmed/18625453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.013 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|